{"title":"RECK as a Potential Crucial Molecule for the Targeted Treatment of Sepsis.","authors":"Yuting Qin, Shuanglin Liao, Jianbo Sun, Huiyun Ye, Jiafu Li, Jiahui Pan, Junbing He, Zhengyuan Xia, Yiming Shao","doi":"10.2147/JIR.S501856","DOIUrl":null,"url":null,"abstract":"<p><p>Reversion inducing cysteine rich protein with kazal motifs (RECK), a Kazal motif-containing protein, regulates pro-inflammatory cytokines production, migration of inflammatory cells, vascular endothelial growth factor (VEGF) and Wnt pathways and plays critical roles in septic inflammatory storms and vascular endothelial dysfunction. Recently, RECK has been defined as the negative regulator of adisintegrin and metalloproteinases (ADAMs) and matrix metalloproteinases (MMPs), which are both membrane \"molecular scissors\" and aggravate the poor prognosis of sepsis. To better understand the roles of RECK and the related mechanisms, we make here a systematic and in-depth review of RECK. We first summarize the findings on structural characteristics of RECK protein and the regulation at the transcription, post-transcription, or protein level of RECK. Then, we discuss the roles of RECK in inflammation, infection, and vascular injury by focusing on the RECK function on ADAMs and MMPs, as well as the pathways of VEGF, WNT, angiopoietin, and notch signaling. In conclusion, RECK participation as a guardian in the development of sepsis provides insight into the strategies of precisely intervening in RECK dysregulationfor the treatment of sepsis.</p>","PeriodicalId":16107,"journal":{"name":"Journal of Inflammation Research","volume":"18 ","pages":"1787-1813"},"PeriodicalIF":4.1000,"publicationDate":"2025-02-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11809362/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Inflammation Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2147/JIR.S501856","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Reversion inducing cysteine rich protein with kazal motifs (RECK), a Kazal motif-containing protein, regulates pro-inflammatory cytokines production, migration of inflammatory cells, vascular endothelial growth factor (VEGF) and Wnt pathways and plays critical roles in septic inflammatory storms and vascular endothelial dysfunction. Recently, RECK has been defined as the negative regulator of adisintegrin and metalloproteinases (ADAMs) and matrix metalloproteinases (MMPs), which are both membrane "molecular scissors" and aggravate the poor prognosis of sepsis. To better understand the roles of RECK and the related mechanisms, we make here a systematic and in-depth review of RECK. We first summarize the findings on structural characteristics of RECK protein and the regulation at the transcription, post-transcription, or protein level of RECK. Then, we discuss the roles of RECK in inflammation, infection, and vascular injury by focusing on the RECK function on ADAMs and MMPs, as well as the pathways of VEGF, WNT, angiopoietin, and notch signaling. In conclusion, RECK participation as a guardian in the development of sepsis provides insight into the strategies of precisely intervening in RECK dysregulationfor the treatment of sepsis.
Reversion induced半胱氨酸rich protein with kazal motif (RECK)是一种含有kazal motif的蛋白,它调节促炎细胞因子的产生、炎症细胞的迁移、血管内皮生长因子(VEGF)和Wnt通路,在脓毒性炎症风暴和血管内皮功能障碍中起关键作用。最近,RECK被定义为adisintegrin and metalloproteinases (ADAMs)和matrix metalloproteinases (MMPs)的负调控因子,两者都是膜“分子剪刀”,加重了脓毒症的不良预后。为了更好地理解RECK的作用和相关机制,我们在此对RECK进行系统深入的综述。我们首先总结了RECK蛋白的结构特征以及在转录、转录后和蛋白水平上的调控。然后,我们通过关注RECK对ADAMs和MMPs的作用,以及VEGF、WNT、血管生成素和notch信号通路,讨论了RECK在炎症、感染和血管损伤中的作用。总之,RECK作为监护人参与脓毒症的发展,为精确干预RECK失调治疗脓毒症的策略提供了见解。
期刊介绍:
An international, peer-reviewed, open access, online journal that welcomes laboratory and clinical findings on the molecular basis, cell biology and pharmacology of inflammation.